Burning Rock Biotech (BNR) Non-Current Receivables: 2022-2024
Historic Non-Current Receivables for Burning Rock Biotech (BNR) over the last 3 years, with Sep 2024 value amounting to $758,000.
- Burning Rock Biotech's Non-Current Receivables fell 85.15% to $758,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $758,000, marking a year-over-year decrease of 85.15%. This contributed to the annual value of $749,000 for FY2023, which is 1.22% up from last year.
- According to the latest figures from Q3 2024, Burning Rock Biotech's Non-Current Receivables is $758,000, which was up 3.55% from $732,000 recorded in Q2 2024.
- In the past 5 years, Burning Rock Biotech's Non-Current Receivables registered a high of $5.1 million during Q1 2023, and its lowest value of $732,000 during Q2 2024.
- For the 3-year period, Burning Rock Biotech's Non-Current Receivables averaged around $2.5 million, with its median value being $753,500 (2023).
- Its Non-Current Receivables has fluctuated over the past 5 years, first surged by 584.32% in 2023, then plummeted by 85.66% in 2024.
- Burning Rock Biotech's Non-Current Receivables (Quarterly) stood at $740,000 in 2022, then rose by 1.22% to $749,000 in 2023, then tumbled by 85.15% to $758,000 in 2024.
- Its Non-Current Receivables was $758,000 in Q3 2024, compared to $732,000 in Q2 2024 and $737,000 in Q1 2024.